FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Late clinical · capacity The affiliate's osteoarthritis therapy released its first US phase 3 results.

  • The affiliate announced top-line results of the first US phase 3 study of TG-C. Source

Roles often seen at this stageClinical & PV · Regulatory affairs · Research & development

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Kolon Life Science

A company in medicines, pharmaceutical ingredients and biologics; an affiliate is running US Phase 3 trials of the osteoarthritis cell and gene therapy TG-C.

TG-C

Phase 3

Cell and gene therapy for osteoarthritis; the first US phase 3 results came in July.

Completion reported

The affiliate announced the first US Phase 3 results for TG-C.

Official role guide

Kolon Life Science careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 1

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 코오롱티슈진, 'TG-C' 美 임상 3상 톱라인 발표 ↗네이트 뉴스 · Published 2026-07-20 · Sources checked 2026-11-15 · Original unavailable